Published in
BMJ Publishing Group, Gut, 9(71), p. 1919.2-1922, 2021
DOI: 10.1136/gutjnl-2021-326312
Links
Tools
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease
Journal article published in 2021 by
Judith Wellens 
,
Matthew Edmans,
Uri Obolski,
Colleen Gc McGregor ,
Peter Simmonds,
Marc Turner,
Lisa Jarvis,
Donal Skelly ,
Susanna Dunachie,
Eleanor Barnes,
David W. Eyre,
Jean-Frederic Colombel,
Serre-Yu Wong ,
Paul Klenerman,
James O. Lindsay
and other authors.
,
Matthew Edmans,
Uri Obolski,
Colleen Gc McGregor ,
Peter Simmonds,
Marc Turner,
Lisa Jarvis,
Donal Skelly ,
Susanna Dunachie,
Eleanor Barnes,
David W. Eyre,
Jean-Frederic Colombel,
Serre-Yu Wong ,
Paul Klenerman,
James O. Lindsay
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 